참고문헌
- Quirk M. Clostridium difficile epidemic strain far reaching. Lancet Infect Dis 2006; 6(2): 74.
- Musher DM, Logan N, Mehendiratta V. Epidemic Clostridium difficile. N Engl J Med 2006; 354(11): 1199- 203 [author reply 203]. https://doi.org/10.1056/NEJMc053654
- Owens RC Jr, Donskey CJ, Gaynes RP, et al., Antimicrobial associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008; 46 (Suppl 1): S19-S31 https://doi.org/10.1086/521859
- Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998; 49: 375-90. https://doi.org/10.1146/annurev.med.49.1.375
- Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002; 162: 2177-84. https://doi.org/10.1001/archinte.162.19.2177
- Owens RC Jr. Clostridium difficile-associated diseases: An emerging threat to patient safety. Pharmacother 2006; 26(3): 229-311 https://doi.org/10.1592/phco.26.2.229
- Gerding DN, Johnson S, Peterson LR, et al., Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16(8): 459-77. https://doi.org/10.1086/648363
- Gaynes R, Rimland D, Killum E, et al., Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004; 38(5): 640-5. https://doi.org/10.1086/381551
- McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficileassociated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162(3): 678-84. https://doi.org/10.1093/infdis/162.3.678
- Dial S, Delaney JA, Barkun AN, et al., Use of gastric acid-suppressive agents and the risk of communityacquired Clostridium difficile-associated disease. JAMA 2005; 294: 2989-95. DOI: 10.1001/jama.294.23.2989
- Shin BM, Kuak EY, Yoo HM, et al., Multicenter study of the prevalence of toxigenic Clostridium difficile in Korea: Results of a retrospective study 2000-2005. J Med Microbiol 2008; 57: 697-701 DOI: 10.1099/jmm.0.4771-0
- Lai KK, Melvin ZS, Menard MJ, et al., Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control. Infect Control Hosp Epidemiol 1997; 18(9): 628-32. https://doi.org/10.1086/647687
- Olson MM, Shanholtzer CJ, Lee JT Jr, et al., Ten years of prospective Clostridium difficile associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994; 15(6): 371-81. https://doi.org/10.1086/646934
- Lee JH, Lee SY, Kim YS, et al., The incidence and clinical features of Clostridium difficile infection; Single center study. Korean J Gastroenterol 2010; 55(3): 175-82 DOI: 10.4166/kjg.2010.55.3.175
- Moshkowitz M, Ben BE, Kline Z, et al., Clinical manifestations and outcome of Pseudomembranous colitis in an elderly population in Israel. Isr Med Assoc J 2004; 6(4): 201-4.
- Simor AE, Bradley SF, Strausbaugh LJ, et al., Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002; 23(11): 696-703. https://doi.org/10.1086/501997
- Weiss K, Bergeron L, Bernatchez et al., Clostridium difficile-associated diarrhea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004. Int J Antimicrob Agents 2007; 30: 309-14 DOI: 10.1016/l.ijantimicag.2007.05.020
- Bouza E, Burillo A, Munoz P. Antimicrobial Therapy of Clostridium difficile-associated diarrhea. Med Clin N Am 2006; 1141-63 DOI:10.1016/j.mcna.2006.07.011
- Kutty PK, Woods CW, Sena AC, et al., Risk factors for and estimated incidence of community-associated Clostridium diffcile infection, North Carolina, USA. Emerg Inf Dis 2010; 16(2): 197-204 DOI: 10.3201/ eid1602.090953 http://www.cdc.gov/ncidod/dhqp/pdf/cdiff/ KuttyEID2010.pdf
- Manian FA, Aradhyula S, Greisnauer S, et al., Is it Clostridium difficile infection or something else? A casecontrol study of 352 hospitalized patients with new-onset diarrhea. South Med J 2007; 100(8): 782-6. https://doi.org/10.1097/SMJ.0b013e318063e9c5
- Obritsch MD, Stroup JS, Carnahan RM, et al., Clostridium difficile-associated diarrhea in a tertiary care medical center. Proc (Bayl Univ Med Cent) 2010; 23(4): 363-7. https://doi.org/10.1080/08998280.2010.11928654
- Dalton BR, Lye-Maccannell T, Henderson EA, et al., Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, nonoutbreak hospital setting. Aliment Pharmacol Ther 2009; 29(6): 626-34. https://doi.org/10.1111/j.1365-2036.2008.03924.x
- Kang CI, Kim SH, Park WB, et al., Bloodstream infection caused by antibiotic-resistant Gram-Negative Bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49(2): 760-6 DOI: 10.1128/AAC.49.2.760-766.2005
- Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346(5): 334-9. https://doi.org/10.1056/NEJMcp011603
- Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998; 26(5): 1027-34 [quiz 35-6]. https://doi.org/10.1086/520276
- Trudel JL, Deschenes M, Mayrand S, et al., Toxic megacolon complicating pseudomembranous enterocolitis. Dis Colon Rectum 1995; 38(10): 1033-8. https://doi.org/10.1007/BF02133974
- Elinav E, Planer D, Gatt ME. Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis. Int J Colorectal Dis 2004; 19(3): 273-6 Epub Nov 15, 2003 https://doi.org/10.1007/s00384-003-0541-9
- Byun TJ, Han DS, Ahn SB et al., Clinical characteristics and changing epidemiology of Clostridium difficileassociated disease (CDAD). Korean J Gastroenterol 2009; 54(1):13-19 DOI: 10.4166/kjg.2009.54.1.13.
- Vaishnavi C. Established and potential risk factors for Clostridium difficile infection. Indian J Med Microbiol 2009; 27(4): 289-300. https://doi.org/10.4103/0255-0857.55436